Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (140 total)
-
Créateur: NETEC
Sujet: Treatment & Care
Type d'élément: Lien hypertexte
Date de la dernière mise à jour: 2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year
Description: Lassa virus infection can result in a broad spectrum of clinical signs and symptoms, from asymptomatic or very minimal symptoms to the severe manifestation, a viral hemorrhagic fever. In addition, the early symptoms of Lassa fever are similar in… -
Créateur: Grillo, Federica, Emanuela Barisione, Lorenzo Ball, Luca Mastracci, and Roberto Fiocca.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-07-28
Description: With the COVID-19 pandemic having reached tremendous proportions, post-mortem series are under the limelight to explain many of the peculiar clinical findings. Pathological descriptions of disease are fundamental for understanding pathogenetic… -
Créateur: WHO
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2015-01
Description: WHO EVD Manual.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: United Kingdom Department of Health
Sujet: Treatment & Care
Type d'élément: Guide
Date de la dernière mise à jour: 2021-08-12
Description: Gov.uk Marburg guidelines. From: Public Health England Published: 5 September 2014 Marburg virus is one of two viruses of the Filovirus family which, along with Ebola virus, can cause a severe and fatal haemorrhagic fever (VHF). -
Créateur: WHO
Sujet: General
Type d'élément: Lien hypertexte
Date de la dernière mise à jour: 2021-08-07
Description: This WHO fact sheet covers Marburg virus disease: Key facts Transmission Symptoms of Marburg virus disease Diagnosis Treatment and vaccines Marburg virus in animals Prevention and control Controlling infection in healthcare settings Marburg viral… -
Créateur: the Medical Countermeasures Working Group of the National Ebola Training and Education Center’s (NETEC’s) Special Pathogens Research Network (SPRN)
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-08-03
Description: This article is a summary of countermeasures for Marburg virus disease focusing on pathogenesis, clinical features, and diagnostics, with an emphasis on therapies and vaccines that have demonstrated potential for use in an emergency situation,… -
Créateur: NLM, NIH
Sujet: Elementos en Español
Type d'élément: Guide
Date de la dernière mise à jour: 2018-05-14
Description: MedlinePlus is the National Institutes of Health's Web site for patients and their families and friends. Produced by the National Library of Medicine, the world’s largest medical library, it brings you information about diseases, conditions, and… -
Créateur: NETEC
Sujet: Infection Control
Type d'élément: Guide
Date de la dernière mise à jour: 2021-01-04
Description: This printable flyer infographic discusses methods for minimizing surgical room contamination from COVID-19. Patients may be contagious prior to symptoms or be asymptomatic. Keep personnel and patients safer by using strategies for minimizing… -
Créateur: NETEC
Sujet: Infection Control
Type d'élément: Guide
Date de la dernière mise à jour: 2024-06-04
Description: This printable flyer infographic discusses methods for minimizing surgical room contamination from a Novel Respiratory Pathogen. Patients may be contagious prior to symptoms or be asymptomatic. Keep personnel and patients safer by using strategies… -
Créateur: NETEC
Sujet: Treatment & Care
Type d'élément: Guide
Date de la dernière mise à jour: 2020-12-10
Description: This printable flyer infographic discusses mAb for COVID-19. Monoclonal antibody therapeutics (mAb) are one of the first available medical countermeasure therapeutics for mild-to-moderate COVID-19 cases. This handout discusses what they are, the…